A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition
- PMID: 23505368
- PMCID: PMC3591319
- DOI: 10.1371/journal.ppat.1003202
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition
Abstract
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broadly neutralizing antibodies 2F5 and 4E10. To date, no immunization regimen in animals or humans has produced HIV-1 neutralizing MPER-specific antibodies. We immunized llamas with gp41-MPER proteoliposomes and selected a MPER-specific single chain antibody (VHH), 2H10, whose epitope overlaps with that of mAb 2F5. Bi-2H10, a bivalent form of 2H10, which displayed an approximately 20-fold increased affinity compared to the monovalent 2H10, neutralized various sensitive and resistant HIV-1 strains, as well as SHIV strains in TZM-bl cells. X-ray and NMR analyses combined with mutagenesis and modeling revealed that 2H10 recognizes its gp41 epitope in a helical conformation. Notably, tryptophan 100 at the tip of the long CDR3 is not required for gp41 interaction but essential for neutralization. Thus bi-2H10 is an anti-MPER antibody generated by immunization that requires hydrophobic CDR3 determinants in addition to epitope recognition for neutralization similar to the mode of neutralization employed by mAbs 2F5 and 4E10.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.PLoS Pathog. 2012;8(7):e1002806. doi: 10.1371/journal.ppat.1002806. Epub 2012 Jul 19. PLoS Pathog. 2012. PMID: 22829767 Free PMC article.
-
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.J Biol Chem. 2014 Oct 24;289(43):29912-26. doi: 10.1074/jbc.M114.569566. Epub 2014 Aug 26. J Biol Chem. 2014. PMID: 25160627 Free PMC article.
-
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.J Virol. 2014 Mar;88(5):2426-41. doi: 10.1128/JVI.02837-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335316 Free PMC article.
-
Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.Curr Opin HIV AIDS. 2017 May;12(3):250-256. doi: 10.1097/COH.0000000000000364. Curr Opin HIV AIDS. 2017. PMID: 28422789 Review.
-
Neutralizing Antibodies Targeting HIV-1 gp41.Viruses. 2020 Oct 23;12(11):1210. doi: 10.3390/v12111210. Viruses. 2020. PMID: 33114242 Free PMC article. Review.
Cited by
-
Identification and characterization of nanobodies specifically against African swine fever virus major capsid protein p72.Front Microbiol. 2022 Oct 13;13:1017792. doi: 10.3389/fmicb.2022.1017792. eCollection 2022. Front Microbiol. 2022. PMID: 36312984 Free PMC article.
-
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.Sci Rep. 2022 Aug 4;12(1):13413. doi: 10.1038/s41598-022-15993-y. Sci Rep. 2022. PMID: 35927444 Free PMC article.
-
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display.Sci Rep. 2021 Feb 4;11(1):3126. doi: 10.1038/s41598-021-82356-4. Sci Rep. 2021. PMID: 33542302 Free PMC article.
-
Nanobody-Based Probes for Subcellular Protein Identification and Visualization.Front Cell Neurosci. 2020 Nov 2;14:573278. doi: 10.3389/fncel.2020.573278. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33240044 Free PMC article. Review.
-
Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.Front Immunol. 2022 Jan 18;12:838082. doi: 10.3389/fimmu.2021.838082. eCollection 2021. Front Immunol. 2022. PMID: 35116045 Free PMC article.
References
-
- Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, et al. (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458 7238: 636–40. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
